InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.93
+0.43 (3.19%)
May 7, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 27.39 billion as of May 7, 2026. Its market cap has increased by 63.31% in one year.
Market Cap
27.39B
Enterprise Value
21.10B
Revenue
2.87B
Ranking
n/a
PE Ratio
27.36
Stock Price
13.93
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 27.39B, an increase of 123.11%. That is a compound annual growth rate of 14.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 27.39B | 15.65% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 42.95B |
| Shanghai Junshi Biosciences | 42.32B |
| Shanghai Henlius Biotech | 40.57B |
| Genscript Biotech | 29.12B |
| Duality Biotherapeutics | 24.93B |
| Keymed Biosciences | 22.26B |
| TransThera Sciences (Nanjing) | 21.54B |
| Zai Lab | 18.96B |